CytoGenix, Inc.

DNA-expression company files for patents for antibacterials, antifungals

Published in Lab Law Weekly, August 27th, 2004

CytoGenix, Inc., (CYGX) has filed new patent applications for "Nucleotides for Prevention and Treatment of Bacterial and Fungal Pathologies" under the Patent Cooperation Treaty (PCT) of the World Intellectual Property Organization.

The company has also filed for protection for the invention titled "Intracellular Generation of Single-stranded DNA" under national phase PCT filings in 12 countries, including France, Germany, Switzerland, China, India, and Israel, and the company received a publication date for the PCT application filed for the invention titled "Treatment of HSV-Related Pathologies Using ssDNA."

Malcolm Skolnick, president and CEO of...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Lab Law Weekly

Source: Lab Law Weekly (2004-08-27)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry